- Home
- IDT vs VRDN Comparison
IDT vs VRDN Comparison
Compare IDT & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IDT
- VRDN
- Stock Information
- Founded
- IDT 1990
- VRDN 2006
- Country
- IDT United States
- VRDN United States
- Employees
- IDT N/A
- VRDN N/A
- Industry
- IDT Telecommunications Equipment
- VRDN Medical Specialities
- Sector
- IDT Telecommunications
- VRDN Health Care
- Exchange
- IDT Nasdaq
- VRDN Nasdaq
- Market Cap
- IDT 1.4B
- VRDN 1.5B
- IPO Year
- IDT 1996
- VRDN N/A
- Fundamental
- Price
- IDT $66.74
- VRDN $18.62
- Analyst Decision
- IDT
- VRDN Strong Buy
- Analyst Count
- IDT 0
- VRDN 11
- Target Price
- IDT N/A
- VRDN $38.80
- AVG Volume (30 Days)
- IDT 123.3K
- VRDN 778.9K
- Earning Date
- IDT 09-29-2025
- VRDN 11-11-2025
- Dividend Yield
- IDT 0.36%
- VRDN N/A
- EPS Growth
- IDT 170.83
- VRDN N/A
- EPS
- IDT 3.79
- VRDN N/A
- Revenue
- IDT $1,223,733,000.00
- VRDN $305,000.00
- Revenue This Year
- IDT $2.59
- VRDN N/A
- Revenue Next Year
- IDT $0.40
- VRDN $35,092.81
- P/E Ratio
- IDT $17.71
- VRDN N/A
- Revenue Growth
- IDT 1.91
- VRDN 5.90
- 52 Week Low
- IDT $37.45
- VRDN $9.90
- 52 Week High
- IDT $71.12
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- IDT 67.30
- VRDN 50.55
- Support Level
- IDT $65.84
- VRDN $17.91
- Resistance Level
- IDT $69.15
- VRDN $20.51
- Average True Range (ATR)
- IDT 1.73
- VRDN 0.93
- MACD
- IDT 0.12
- VRDN -0.15
- Stochastic Oscillator
- IDT 59.77
- VRDN 27.31
About IDT IDT Corporation Class B
IDT Corp is a multinational holding company. It operates in the telecommunications and payment industries. It has four reportable business segments, Fintech, National Retail Solutions; net2phone and Traditional Communications, The Fintech segment is comprised of National Retail Solutions (NRS), an operator of a nationwide point of sale (POS) network providing payment processing, digital advertising, transaction data, and ancillary services, and BOSS Money, a provider of international money remittance and related value/payment transfer services. The net2phone segment provides unified cloud communications and telephony services to business customers.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).